These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 16631149

  • 1. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
    Murdoch CE, Zhang M, Cave AC, Shah AM.
    Cardiovasc Res; 2006 Jul 15; 71(2):208-15. PubMed ID: 16631149
    [Abstract] [Full Text] [Related]

  • 2. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
    Sirker A, Zhang M, Murdoch C, Shah AM.
    Am J Nephrol; 2007 Jul 15; 27(6):649-60. PubMed ID: 17901689
    [Abstract] [Full Text] [Related]

  • 3. NADPH oxidase and heart failure.
    Murdoch CE, Grieve DJ, Cave AC, Looi YH, Shah AM.
    Curr Opin Pharmacol; 2006 Apr 15; 6(2):148-53. PubMed ID: 16483850
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress and heart failure.
    Byrne JA, Grieve DJ, Cave AC, Shah AM.
    Arch Mal Coeur Vaiss; 2003 Mar 15; 96(3):214-21. PubMed ID: 12722552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H, Kinugawa S, Matsushima S.
    Cardiovasc Res; 2009 Feb 15; 81(3):449-56. PubMed ID: 18854381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.
    Cave A, Grieve D, Johar S, Zhang M, Shah AM.
    Philos Trans R Soc Lond B Biol Sci; 2005 Dec 29; 360(1464):2327-34. PubMed ID: 16321803
    [Abstract] [Full Text] [Related]

  • 12. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle.
    Nediani C, Borchi E, Giordano C, Baruzzo S, Ponziani V, Sebastiani M, Nassi P, Mugelli A, d'Amati G, Cerbai E.
    J Mol Cell Cardiol; 2007 Apr 29; 42(4):826-34. PubMed ID: 17346742
    [Abstract] [Full Text] [Related]

  • 13. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.
    McMullen JR, Jennings GL.
    Clin Exp Pharmacol Physiol; 2007 Apr 29; 34(4):255-62. PubMed ID: 17324134
    [Abstract] [Full Text] [Related]

  • 14. [The role of oxidative stress in heart failure].
    Gál R, Halmosi R.
    Orv Hetil; 2015 Nov 22; 156(47):1916-20. PubMed ID: 26568107
    [Abstract] [Full Text] [Related]

  • 15. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.
    Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H.
    J Nutr Biochem; 2010 Dec 22; 21(12):1238-50. PubMed ID: 20185286
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.
    Octavia Y, Brunner-La Rocca HP, Moens AL.
    Free Radic Biol Med; 2012 Jan 15; 52(2):291-7. PubMed ID: 22080085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, Holland SM, Sorrentino S, Manes C, Schieffer B, Drexler H, Landmesser U.
    Circ Res; 2007 Mar 30; 100(6):894-903. PubMed ID: 17332431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.